Hello Everyone, i hope you all will be doing good. I have brought an analysis on Pharmaceuticals stock which has given neat and clean short term consolidation zone breakout. Stock name is Alembic Pharmaceuticals and it is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.
Leading Pharma company:- The company has 3 R&D and 5 manufacturing facilities. Alembic is among the top 25 players in domestic formulations market. The company has a portfolio of about 200 formulation brands, of which three are among the top 300 domestic formulation brands in India. It has a share of 1.5% in the domestic market.
Market Share:- The company has 1.5% share of the Indian Pharma market with 4 brands with revenue of Rs.1 bn. Its products like Roxid has ~95% market share, Althrocin (~90%), Deltone (~67%), Gerijoint (~50%), Elata (~50%) etc. Prescription wise Alembic ranks at 18th Position.
Technically stock has given breakout of short term consolidation breakout of Rectangle pattern with good volume, there is higher probability that we can see this stock towards 1500+ in short term and 2500+ in long term. Stock is above 200-DEMA, and MACD Indicator is showing bullish crossover. Volume indicator is suggesting huge bullishness in coming few months.
Market Cap ₹ 21,237 Cr. Current Price ₹ 1,080 High / Low ₹ 1,119 / 682 Stock P/E 34.6 Book Value ₹ 245 Dividend Yield 1.02 % ROCE 13.1 % ROE 13.3 % Face Value ₹ 2.00 Industry PE 34.6 Debt ₹ 513 Cr. EPS ₹ 31.3 Promoter holding 69.6 % Intrinsic Value ₹ 490 Pledged percentage 0.00 % EVEBITDA 22.6 Change in Prom Hold 0.00 % Profit Var 5Yrs 1.07 % Sales growth 5Years 9.62 % Return over 5years 16.0 % Debt to equity 0.11 Net profit ₹ 616 Cr. ROE 5Yr 15.9 % Profit growth 77.2 % Earnings yield 3.17 %
Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades.
Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.